Augma Biomaterials

Augma Biomaterials is a medical device company specializing in the development and manufacturing of innovative bone substitute materials for dental applications. The company's core technology is based on Biphasic Calcium Sulfate (BCS), which provides a biocompatible, osteoconductive scaffold that is completely replaced by the patient's own bone over time. Their flagship products, such as Bond Apatite and 3D Bond, are designed to simplify bone grafting procedures by eliminating the need for membranes and reducing surgical complexity. Augma's solutions are used globally by dental surgeons for indications including socket preservation, ridge augmentation, and sinus lifts. The company is headquartered in Israel and maintains a significant commercial presence in the United States.